Literature DB >> 14616496

Successful treatment of in-transit melanoma metastases using topical 2-4 dinitrochlorobenzene.

Jamie von Nida1, Chris Quirk.   

Abstract

A 78-year-old woman presented with multiple histologically proven in-transit melanoma metastases involving the lower half of the left leg. Initial therapy with liquid nitrogen cryotherapy had some short-lived success but was not tolerated by the patient. As further lesions began to develop, daily topical application of 2% 2-4 dinitrochlorobenzene to the lesions was commenced. During the first 2 years of therapy a partial response was achieved, with treated lesions regressing while new lesions developed. Eventually a long-term remission of almost 2 years with no clinical evidence of cutaneous melanoma deposits was achieved. This treatment did not prevent metastatic lymph node and ultimately fatal liver involvement. Topical immunotherapy can be a useful adjunct in the treatment of cutaneous melanoma metastases, particularly in those patients who are unable to tolerate other destructive modalities of therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14616496     DOI: 10.1046/j.1440-0960.2003.00009.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  6 in total

Review 1.  Use of Contact Immunotherapy in the Treatment of Skin Diseases Other than Alopecia Areata.

Authors:  Kun-Wei Lai; Tsen-Fang Tsai
Journal:  Dermatol Ther (Heidelb)       Date:  2022-09-22

2.  Effective topical treatment of subcutaneous murine B16F10-Nex2 melanoma by the antimicrobial peptide gomesin.

Authors:  Elaine G Rodrigues; Andrey Ss Dobroff; Clarissa F Cavarsan; Thaysa Paschoalin; Leonardo Nimrichter; Renato A Mortara; Edson Lucas Santos; Marcos A Fázio; Antonio Miranda; Sirlei Daffre; Luiz R Travassos
Journal:  Neoplasia       Date:  2008-01       Impact factor: 5.715

3.  Chemoimmunotherapy for cutaneous melanoma with dacarbazine and epifocal contact sensitizers: results of a nationwide survey of the German Dermatologic Co-operative Oncology Group.

Authors:  P Terheyden; A-K Kortüm; H-J Schulze; B Durani; R Remling; C Mauch; V Junghans; D Schadendorf; U Beiteke; M Jünger; J C Becker; E-B Bröcker
Journal:  J Cancer Res Clin Oncol       Date:  2007-03-03       Impact factor: 4.322

Review 4.  Therapeutic vaccination immunomodulation: forming the basis of all cancer immunotherapy.

Authors:  Brendon J Coventry
Journal:  Ther Adv Vaccines Immunother       Date:  2019-08-01

5.  Lithraea caustic (Litre) Extract Promotes an Antitumor Response Against B16 Melanoma.

Authors:  Claudia Robles-Planells; Sofia A Michelson; Javier Mena; Daniela Escrig; Juan L Rojas; Giselle Sanchez-Guerrero; Ronny Hernández; Carlos Barrera-Avalos; Leonel E Rojo; Daniela Sauma; Alexis M Kalergis; Mónica Imarai; Ricardo Fernández; Carolina A Robles; Elías Leiva-Salcedo; Rocio Santander; Alejandro Escobar; Claudio Acuña-Castillo
Journal:  Front Pharmacol       Date:  2019-10-22       Impact factor: 5.810

Review 6.  Hapten-induced contact hypersensitivity, autoimmune reactions, and tumor regression: plausibility of mediating antitumor immunity.

Authors:  Dan A Erkes; Senthamil R Selvan
Journal:  J Immunol Res       Date:  2014-05-15       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.